scorecardresearch
Add as a preferred source on Google
Saturday, January 24, 2026
TopicSinovac

Topic: Sinovac

China’s Sinovac doesn’t provide enough antibodies to neutralise Omicron, Hong Kong study finds

The initial lab findings may have sweeping consequences for the millions of people relying on the Chinese shot to protect them against Covid.

World finally accepts China’s much-maligned Sinovac shot

Sinovac has already shipped some 380 mn doses, more than AstraZeneca and second only to Pfizer, worldwide. But it still hasn’t published any data in an academic journal.

Indonesia finds China’s Sinovac 100% effective against death in 28-day real world study

Indonesia tracked 25,374 health workers in Jakarta for 28 days after receiving their second dose. Health Minister Budi Gunadi said 94% of them had been vaccinated.

With India & US stumbling, the world is turning to China for vaccines

Demand is expected to rise if WHO authorises China’s Sinovac & Sinopharm vaccines, allowing developing countries in Asia, Africa & Latin America to access them through Covax.

Mexico goes for 32mn Chinese vaccine doses, Australia’s warning to doctors & other Covid news

As the Covid-19 pandemic shows no signs of letting up, ThePrint highlights the most important stories on the crisis from across the globe.

Bolsonaro goes with China’s Sinovac for now as India delays Covishield delivery to Brazil

India had agreed to send 2 million doses of Covishield vaccine to Brazil, but is yet to give approval for a special flight to transport the shipment.

Sinovac defends Covid vaccine efficacy as confusing data fuels uncertainty

Vastly different efficacy rates in 4 clinical trial sites raised concerns over whether Sinovac, that’s key to vaccine drives in some of the world's hotspots, will be effective.

How effective is China’s Sinovac Covid vaccine? Data gives four different answers

Sinovac’s shot, is fuelling skepticism over Chinese vaccines, which have disclosed less safety and testing information than western front-runners.

Indonesia approves China’s Sinovac Covid vaccine for emergency use

The vaccine was found to be about 65% effective against Covid in late stage-trials in the city of Bandung. The emergency use approval is the first for Sinovac’s shot outside of China.

China’s Sinovac Covid vaccine 78% effective in late-stage trials in Brazil

The protection rate, confirmed by Sao Paulo state officials, was derived from Sinovac’s most advanced final-phase trials in Brazil involving about 13,000 participants.

On Camera

Controversial dog-walker IAS Sanjeev Khirwar is back in Delhi. What happened to his wife?

In 2022, athletes claimed they were asked to wind up training early at Thyagraj Stadium so that the IAS couple could walk their dog. Then came the memes and public outrage.

IndiGo profit plunges 78% as Dec meltdown with 3k flight cancellations takes a toll

Net income for InterGlobe Aviation Ltd slipped 78 percent to Rs 5.5 billion for the three months ended Dec 31 compared with the year-ago period.

Rafale saga: 25 yrs of detours, deadlocks & political hesitation. Now IAF getting what it always wanted

Instead of buying more Mirages outright in early 2000s, the requirement was tweaked in favour of a medium-weight, multi-role fighter with Mirage-like performance. 

Pakistan se azaadi. Grow up India, stop giving it prime real estate in your psyche

Pakistan not only has zero chance of catching up with India in most areas, but will inevitably see the gap rising. Its leaders will offer its people the same snake oil in different bottles.